BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 34637844)

  • 1. Linking cell-surface GRP78 to cancer: From basic research to clinical value of GRP78 antibodies.
    Hernandez I; Cohen M
    Cancer Lett; 2022 Jan; 524():1-14. PubMed ID: 34637844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of anti-GRP78 autoantibodies to cell surface GRP78 increases tissue factor procoagulant activity via the release of calcium from endoplasmic reticulum stores.
    Al-Hashimi AA; Caldwell J; Gonzalez-Gronow M; Pizzo SV; Aboumrad D; Pozza L; Al-Bayati H; Weitz JI; Stafford A; Chan H; Kapoor A; Jacobsen DW; Dickhout JG; Austin RC
    J Biol Chem; 2010 Sep; 285(37):28912-23. PubMed ID: 20605795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unveiling the dark side of glucose-regulated protein 78 (GRP78) in cancers and other human pathology: a systematic review.
    Akinyemi AO; Simpson KE; Oyelere SF; Nur M; Ngule CM; Owoyemi BCD; Ayarick VA; Oyelami FF; Obaleye O; Esoe DP; Liu X; Li Z
    Mol Med; 2023 Aug; 29(1):112. PubMed ID: 37605113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell Surface GRP78 as a Death Receptor and an Anticancer Drug Target.
    Ge R; Kao C
    Cancers (Basel); 2019 Nov; 11(11):. PubMed ID: 31766302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scratching the Surface-An Overview of the Roles of Cell Surface GRP78 in Cancer.
    Chen J; Lynn EG; Yousof TR; Sharma H; MacDonald ME; Byun JH; Shayegan B; Austin RC
    Biomedicines; 2022 May; 10(5):. PubMed ID: 35625836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chimeric antigen receptor T cells targeting cell surface GRP78 efficiently kill glioblastoma and cancer stem cells.
    Wang S; Wei W; Yuan Y; Sun B; Yang D; Liu N; Zhao X
    J Transl Med; 2023 Jul; 21(1):493. PubMed ID: 37481592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies against the cell surface-associated chaperone GRP78 stimulate tumor growth via tissue factor.
    Al-Hashimi AA; Lebeau P; Majeed F; Polena E; Lhotak Š; Collins CAF; Pinthus JH; Gonzalez-Gronow M; Hoogenes J; Pizzo SV; Crowther M; Kapoor A; Rak J; Gyulay G; D'Angelo S; Marchiò S; Pasqualini R; Arap W; Shayegan B; Austin RC
    J Biol Chem; 2017 Dec; 292(51):21180-21192. PubMed ID: 29066620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiological Roles of the Autoantibodies to the 78-Kilodalton Glucose-Regulated Protein (GRP78) in Cancer and Autoimmune Diseases.
    Gonzalez-Gronow M; Pizzo SV
    Biomedicines; 2022 May; 10(6):. PubMed ID: 35740249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose-regulated protein (GRP78) is an important cell surface receptor for viral invasion, cancers, and neurological disorders.
    Gonzalez-Gronow M; Gopal U; Austin RC; Pizzo SV
    IUBMB Life; 2021 Jun; 73(6):843-854. PubMed ID: 33960608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucose-regulated protein 78 (GRP78) as a potential novel biomarker and therapeutic target in multiple myeloma.
    Ninkovic S; Harrison SJ; Quach H
    Expert Rev Hematol; 2020 Nov; 13(11):1201-1210. PubMed ID: 32990063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-GRP78 autoantibodies induce endothelial cell activation and accelerate the development of atherosclerotic lesions.
    Crane ED; Al-Hashimi AA; Chen J; Lynn EG; Won KD; Lhoták Š; Naeim M; Platko K; Lebeau P; Byun JH; Shayegan B; Krepinsky JC; Rayner KJ; Marchiò S; Pasqualini R; Arap W; Austin RC
    JCI Insight; 2018 Dec; 3(24):. PubMed ID: 30568038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell surface expression of 78-kDa glucose-regulated protein (GRP78) mediates diabetic nephropathy.
    Van Krieken R; Mehta N; Wang T; Zheng M; Li R; Gao B; Ayaub E; Ask K; Paton JC; Paton AW; Austin RC; Krepinsky JC
    J Biol Chem; 2019 May; 294(19):7755-7768. PubMed ID: 30914477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell surface GRP78: An emerging imaging marker and therapeutic target for cancer.
    Farshbaf M; Khosroushahi AY; Mojarad-Jabali S; Zarebkohan A; Valizadeh H; Walker PR
    J Control Release; 2020 Dec; 328():932-941. PubMed ID: 33129921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-Surface GRP78-Targeted Chimeric Antigen Receptor T Cells Eliminate Lung Cancer Tumor Xenografts.
    Wang S; Wei W; Yuan Y; Guo J; Liang D; Zhao X
    Int J Mol Sci; 2024 Jan; 25(1):. PubMed ID: 38203736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell surface GRP78 regulates TGFβ1-mediated profibrotic responses
    Trink J; Ahmed U; O'Neil K; Li R; Gao B; Krepinsky JC
    Front Pharmacol; 2023; 14():1098321. PubMed ID: 36909183
    [No Abstract]   [Full Text] [Related]  

  • 16. The COOH-Terminal Proline-Rich Region of GRP78 Is a Key Regulator of Its Cell Surface Expression and Viability of Tamoxifen-Resistant Breast Cancer Cells.
    Tseng CC; Zhang P; Lee AS
    Neoplasia; 2019 Aug; 21(8):837-848. PubMed ID: 31306849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and characterization of a novel GRP78-specific single-chain variable fragment (scFv) using ribosome display method.
    Shabani S; Moghadam MF; Gargari SLM
    Med Oncol; 2021 Aug; 38(9):115. PubMed ID: 34390413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxidase from foxtail millet bran exerts anti-colorectal cancer activity
    Shan S; Niu J; Yin R; Shi J; Zhang L; Wu C; Li H; Li Z
    Acta Pharm Sin B; 2022 Mar; 12(3):1254-1270. PubMed ID: 35530132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beyond the endoplasmic reticulum: atypical GRP78 in cell viability, signalling and therapeutic targeting.
    Ni M; Zhang Y; Lee AS
    Biochem J; 2011 Mar; 434(2):181-8. PubMed ID: 21309747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced GRP78 protein expression via the IRE1α/ASK1/p38 MAPK pathway during As
    Yuan J; Yao C; Tang J; Liu Y; Huang C; Yu S; Wei H; Han Y; Chen G
    Toxicology; 2021 Oct; 462():152962. PubMed ID: 34560123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.